Syndax Pharmaceuticals (SNDX) Equity Ratio (2016 - 2025)
Syndax Pharmaceuticals (SNDX) has 11 years of Equity Ratio data on record, last reported at 0.12 in Q4 2025.
- For Q4 2025, Equity Ratio fell 69.31% year-over-year to 0.12; the TTM value through Dec 2025 reached 0.12, down 69.31%, while the annual FY2025 figure was 0.12, 69.31% down from the prior year.
- Equity Ratio reached 0.12 in Q4 2025 per SNDX's latest filing, down from 0.21 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.95 in Q1 2023 and bottomed at 0.12 in Q4 2025.
- Average Equity Ratio over 5 years is 0.74, with a median of 0.89 recorded in 2022.
- Peak YoY movement for Equity Ratio: skyrocketed 60.35% in 2021, then plummeted 75.69% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.91 in 2021, then increased by 3.51% to 0.94 in 2022, then dropped by 3.81% to 0.9 in 2023, then crashed by 56.04% to 0.4 in 2024, then tumbled by 69.31% to 0.12 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.12 in Q4 2025, 0.21 in Q3 2025, and 0.26 in Q2 2025.